Vitamin C as an Adjunct in Periodontal Treatment in Type 2 Diabetes Mellitus Patients
Phase 2
- Conditions
- PeriodontitisDiabetes Mellitus Type 2 With Hyperglycemia
- Interventions
- Other: placeboDrug: Vitamin C 500 MG Oral Capsule
- Registration Number
- NCT03269799
- Lead Sponsor
- Mahidol University
- Brief Summary
Periodontitis patients with uncontrolled type 2 diabetes mellitus will receive non-surgical periodontal treatment and then be supplemented with daily 500 mg vitamin C (test group) or placebo (control group) for 2 months. Clinical parameters will be retrieved at baseline, at the end of week 4 and at the end of week 8.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- uncontrolled type 2 diabetes mellitus
- periodontitis
Read More
Exclusion Criteria
- complications from diabetes mellitus, e.g., renal insufficiency
- receive insulin
- diseases that interfere with wound healing, e.g., HIV
- receive one of the followings: tetracycline, acetaminophen, NSAID, warfarin, aluminum-containing antacids, barbiturates, phenobarbital, pentobarbital, secobarbital, hormone replacement therapy, chemotherapeutic drug, protease inhibitor
- receive other vitamins or antibiotics within 6 months
- smoking
- pregnancy
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description control group placebo placebo test group Vitamin C 500 MG Oral Capsule vitamin C 500 mg oral capsule
- Primary Outcome Measures
Name Time Method sulcus bleeding index baseline, change from baseline sulcus bleeding index at 4 weeks, change from baseline sulcus bleeding index at 8 weeks bleeding upon probing of gingival sulcus from the most severe periodontitis tooth
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Burapha University Hospital
🇹ðŸ‡Chon Buri, Thailand